Liaoning GST Pharmaceutical Technology Co., Ltd. invested and constructed by Tianjin Guangshun Chemical Co., Ltd., which is a high-tech enterprise integrating R&D, production and sales of pharmaceutical intermediates. The company is mainly engaged in the research and development and production of the intermediates of antineoplastic drugs, anti-inflammatory drugs and statin lipid-lowering drugs. The company has R&D center, standardization experiment center, small GMP pilot conversion workshop and enterprise base.
The company now has 20 patents for independent research and development. The company focuses on the research and development and manufacturing of advanced pharmaceutical raw materials and intermediates, especially in the field of anti-tumor, diabetes and cardiovascular and cerebrovascular drug intermediates with leading domestic technology and manufacturing advantages. At the same time, the company also provides impurity tracking, stability analysis and CTD documentation and other technical services. The company is equipped with 50 sets of 100l-5000l reaction kettle, with an annual manufacturing capacity of 300 tons. The company can realize -10 0℃~240℃ high low temperature reaction, and on the synthesis of heterocyclic compounds with leading technical ability. The company started ISO certification in 2016.